These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Update on erectile dysfunction in prostate cancer patients. Kendirci M; Bejma J; Hellstrom WJ Curr Opin Urol; 2006 May; 16(3):186-95. PubMed ID: 16679857 [TBL] [Abstract][Full Text] [Related]
5. [Management of erectile dysfunction after radical prostatectomy]. Droupy S Prog Urol; 2009 Dec; 19(12):893-6. PubMed ID: 19963187 [TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Walsh PC Urol Clin North Am; 1987 Nov; 14(4):663-73. PubMed ID: 3314061 [TBL] [Abstract][Full Text] [Related]
7. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. Gralnek D; Wessells H; Cui H; Dalkin BL J Urol; 2000 Apr; 163(4):1166-9; discussion 1169-70. PubMed ID: 10737488 [TBL] [Abstract][Full Text] [Related]
8. Association of surgeon subjective characterization of nerve sparing quality with potency following laparoscopic radical prostatectomy. Levinson AW; Pavlovich CP; Ward NT; Link RE; Mettee LZ; Su LM J Urol; 2008 Apr; 179(4):1510-4. PubMed ID: 18295270 [TBL] [Abstract][Full Text] [Related]
9. Management of erectile dysfunction after radical prostatectomy. Hall MC Semin Urol Oncol; 1995 Aug; 13(3):215-23. PubMed ID: 8521135 [TBL] [Abstract][Full Text] [Related]
10. Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. Marien T; Sankin A; Lepor H J Urol; 2009 Apr; 181(4):1817-22. PubMed ID: 19233413 [TBL] [Abstract][Full Text] [Related]
11. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457 [TBL] [Abstract][Full Text] [Related]
12. Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation. Haffner MC; Landis PK; Saigal CS; Carter HB; Freedland SJ Urology; 2005 Aug; 66(2):371-6. PubMed ID: 16040103 [TBL] [Abstract][Full Text] [Related]
13. Recent data upon impotence, incontinence and quality of life issues concerning radical prostatectomy. Alivizatos G; Skolarikos A; Laguna P Arch Esp Urol; 2003 Apr; 56(3):321-30. PubMed ID: 12768997 [TBL] [Abstract][Full Text] [Related]
14. [Preservation of erectile function and radical prostatectomy: what to expect in 2005?]. Kanso C; Amar E; Bondil P; Boccon-Gibod L; Delmas V Prog Urol; 2005 Sep; 15(4):621-5. PubMed ID: 16459674 [TBL] [Abstract][Full Text] [Related]
15. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. Matthew AG; Goldman A; Trachtenberg J; Robinson J; Horsburgh S; Currie K; Ritvo P J Urol; 2005 Dec; 174(6):2105-10. PubMed ID: 16280737 [TBL] [Abstract][Full Text] [Related]
16. [Preservation of erectile function in patients with prostatic cancer after radical prostatectomy]. Pushkar' DIu; Bormotin AV; Rasner PI Urologiia; 2007; (1):5-10. PubMed ID: 17471990 [TBL] [Abstract][Full Text] [Related]